NEW YORK (GenomeWeb News) — Gene Logic has promoted Thomas Barnes to senior vice president of discovery, a position that will put him in charge of drug repositioning, the company said this week.
Barnes will take over the position from Louis Tartaglia, who is resigning from the job to become a partner in a venture capital firm. 
Barnes formerly was co-founder of drug repositioning at Millennium Pharmaceuticals, which is now owned by Gene Logic.


To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Robert Redfield is floated as the next director of the US Centers for Disease Control and Prevention, the Washington Post reports.

The New York Times writes that the National Institutes of Health's All of Us Research Program is "ambitious" and that some are concerned it might be overly so.

Representative Lamar Smith's criticism of the National Science Foundation has "changed the nature of the conversation," according to ScienceInsider.

In PLOS this week: non-coding RNA function in yeast, transcriptomic profiles of malaria parasites, and more.